Published in Pharma Law Weekly, February 15th, 2005
It is estimated that as many as 50% of all known drugs interact with this form of cytochrome P450 and as such it represents a major problem for drug developers.
Astex has been actively involved in human cytochrome P450 research since the company's formation and Astex scientists were the first group to successfully solve the crystal structures of human cytochromes P450, 3A4 and 2C9.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.